IT8348724A0 - Antifungina ed antitumorale, compoderivato di monosialo ganglioside sizioni che lo contengono e procedi dotato di attivita' antibatterica, mento per la loro preparazione - Google Patents

Antifungina ed antitumorale, compoderivato di monosialo ganglioside sizioni che lo contengono e procedi dotato di attivita' antibatterica, mento per la loro preparazione

Info

Publication number
IT8348724A0
IT8348724A0 IT8348724A IT4872483A IT8348724A0 IT 8348724 A0 IT8348724 A0 IT 8348724A0 IT 8348724 A IT8348724 A IT 8348724A IT 4872483 A IT4872483 A IT 4872483A IT 8348724 A0 IT8348724 A0 IT 8348724A0
Authority
IT
Italy
Prior art keywords
compoderivative
sitions
antifungal
anticancer
mention
Prior art date
Application number
IT8348724A
Other languages
English (en)
Other versions
IT1168205B (it
Inventor
Tubaro Ezio
Cavallo Giovanni
Original Assignee
Wellcome Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Italia filed Critical Wellcome Italia
Publication of IT8348724A0 publication Critical patent/IT8348724A0/it
Priority to IT48724/83A priority Critical patent/IT1168205B/it
Priority to US06/632,200 priority patent/US4728641A/en
Priority to EP84108621A priority patent/EP0136438B1/en
Priority to DE8484108621T priority patent/DE3485680D1/de
Priority to AT84108621T priority patent/ATE75480T1/de
Priority to HU842819A priority patent/HU198091B/hu
Priority to JP59151160A priority patent/JPS6084296A/ja
Priority to DK356984A priority patent/DK166828B1/da
Priority to ES534494A priority patent/ES8603191A1/es
Application granted granted Critical
Publication of IT1168205B publication Critical patent/IT1168205B/it
Priority to US07/123,763 priority patent/US4831021A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT48724/83A 1983-07-21 1983-07-21 Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione IT1168205B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT48724/83A IT1168205B (it) 1983-07-21 1983-07-21 Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
US06/632,200 US4728641A (en) 1983-07-21 1984-07-18 Ganglioside derivatives
AT84108621T ATE75480T1 (de) 1983-07-21 1984-07-20 Gangliosid-derivate.
DE8484108621T DE3485680D1 (de) 1983-07-21 1984-07-20 Gangliosid-derivate.
EP84108621A EP0136438B1 (en) 1983-07-21 1984-07-20 Ganglioside derivatives
HU842819A HU198091B (en) 1983-07-21 1984-07-20 Process for producing ganglioside derivatives and pharmaceutical compositions comprising same as active ingedient
JP59151160A JPS6084296A (ja) 1983-07-21 1984-07-20 ガングリオシド誘導体
DK356984A DK166828B1 (da) 1983-07-21 1984-07-20 Mono-sialo gangliosid gm1p, praeparater indeholdende dette samt anvendelse deraf til fremstilling af et laegemiddel
ES534494A ES8603191A1 (es) 1983-07-21 1984-07-20 Un procedimiento para preparar un derivado de mono-sialo-gangliosido
US07/123,763 US4831021A (en) 1983-07-21 1987-11-23 Ganglioside derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48724/83A IT1168205B (it) 1983-07-21 1983-07-21 Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione

Publications (2)

Publication Number Publication Date
IT8348724A0 true IT8348724A0 (it) 1983-07-21
IT1168205B IT1168205B (it) 1987-05-20

Family

ID=11268264

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48724/83A IT1168205B (it) 1983-07-21 1983-07-21 Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione

Country Status (9)

Country Link
US (2) US4728641A (it)
EP (1) EP0136438B1 (it)
JP (1) JPS6084296A (it)
AT (1) ATE75480T1 (it)
DE (1) DE3485680D1 (it)
DK (1) DK166828B1 (it)
ES (1) ES8603191A1 (it)
HU (1) HU198091B (it)
IT (1) IT1168205B (it)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH660557A5 (fr) * 1984-10-26 1987-05-15 Nestle Sa Composition anti-bacterienne et procede de preparation de ses constituants actifs.
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0653764B2 (ja) * 1985-07-31 1994-07-20 三井東圧化学株式会社 モノシアロガングリオシドの製造法
EP0249008B1 (de) * 1986-05-09 1993-09-15 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Verwendung von spezifischen Monosacchariden zur Herstellung eines Arzneimittels zur Verhinderung von Metastasen maligner Tumore
IT1208751B (it) * 1986-06-30 1989-07-10 Fidia Farmaceutici Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali
EP0508493A1 (en) * 1986-08-06 1992-10-14 Mect Corporation Ganglioside related compounds and method of producing the same
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
AU7153991A (en) * 1989-12-13 1991-07-18 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
AU6902691A (en) * 1989-12-13 1991-07-18 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
DE4204907A1 (de) * 1992-02-14 1993-08-19 Reutter Werner Neuartige glykokonjugate mit n-substituierten neuraminsaeuren als mittel zur stimulierung des immunsystems
TW261533B (it) * 1992-07-16 1995-11-01 Kirin Brewery
DE69328435T2 (de) * 1992-10-22 2000-09-14 Kirin Brewery Neues sphingolglycolipid und verwendung davon
KR100281265B1 (ko) * 1993-04-15 2001-02-01 마나배 게이사꾸 신규한 스핀고당지질 및 그의 사용
DE19602108A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
US5747476A (en) 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
DE19643585A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sphingolipide
WO2002018401A2 (en) * 2000-09-01 2002-03-07 Neuronyx, Inc. Novel synthetic gangliosides
AU2001288671A1 (en) * 2000-09-01 2002-03-13 Neuronyx, Inc. Novel synthetic gangliosides
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
EP1358910A1 (de) * 2002-05-02 2003-11-05 B.R.A.H.M.S Aktiengesellschaft Verfahren und Mittel zur Prävention, Hemmung und Therapie von Krebserkrankungen
EP1367395A1 (de) * 2002-05-02 2003-12-03 B.R.A.H.M.S Aktiengesellschaft Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern
US9969977B2 (en) * 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
EP1603932B1 (en) 2003-03-06 2012-10-03 Seneb Biosciences Inc. Methods and compositions for the enzymatic synthesis of gangliosides
JP4965063B2 (ja) * 2004-05-07 2012-07-04 雪印メグミルク株式会社 口腔内細菌叢改善剤、抗菌剤及び生育促進剤。
WO2006032111A1 (en) 2004-09-23 2006-03-30 National Ventilation Laboratory Pty Ltd Hybrid ventilator
CN101835891A (zh) * 2007-06-15 2010-09-15 加内特生物治疗学股份有限公司 运用体外培养增殖的自我更新型集落形成细胞治疗疾病和功能紊乱症
US20090239834A1 (en) * 2008-03-21 2009-09-24 Braincells, Inc. Mcc-257 modulation of neurogenesis
DE102010024041A1 (de) * 2010-05-16 2013-04-04 Alfred Kroll Symtomfreiheit der Atemwege

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT295036B (de) * 1968-11-29 1971-12-27 Leikola Erkki E Verfahren zur Herstellung von neuen Produkten tierischen Ursprungs
US4125492A (en) * 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
FR2478104B1 (fr) * 1980-03-17 1986-08-08 Merieux Inst Nouveaux derives de gangliosides, leur preparation et leur application
WO1981003175A1 (en) * 1980-05-09 1981-11-12 H Leffler Carbohydrate derivatives for inhibiting bacterial adherence
CH658458A5 (fr) * 1981-12-17 1986-11-14 Lucchini Lab Sa Procede pour l'obtention du lacto-n-norhexaosyl ceramide.

Also Published As

Publication number Publication date
EP0136438A3 (en) 1987-05-13
ATE75480T1 (de) 1992-05-15
HUT35690A (en) 1985-07-29
DK356984D0 (da) 1984-07-20
DK356984A (da) 1985-01-22
ES534494A0 (es) 1985-12-01
IT1168205B (it) 1987-05-20
JPS6084296A (ja) 1985-05-13
EP0136438B1 (en) 1992-04-29
EP0136438A2 (en) 1985-04-10
US4728641A (en) 1988-03-01
DE3485680D1 (de) 1992-06-04
HU198091B (en) 1989-07-28
US4831021A (en) 1989-05-16
ES8603191A1 (es) 1985-12-01
DK166828B1 (da) 1993-07-19

Similar Documents

Publication Publication Date Title
IT8348724A0 (it) Antifungina ed antitumorale, compoderivato di monosialo ganglioside sizioni che lo contengono e procedi dotato di attivita' antibatterica, mento per la loro preparazione
PH22614A (en) 9-amino-1,2,3,4-tetrahydroacridin-1-alpha and related compounds and their use as medicament
IT1181701B (it) Lafa-maltosio cristallino e prodotti alimentari che lo contengono,nonche' procedimento per la loro preparazione
IT1200139B (it) Composti disazoici basici, loro preparazione e loro impiego come coloranti
IT1190353B (it) Cefem composti ad attivita' antibatterica,relativo procedimento di preparazione ed intermedi per questo
IT1199973B (it) Composti dis-o trisazoici,loro preparazione e loro impiego come coloranti
IL75572A0 (en) Sulphonylureas,their preparation and their use as herbicides
IT8368343A0 (it) Fluorometiltioossacefalosporine aventi attivita antibatterica composizioni antibatteriche che le con tengono e procedimento per la loro preparazione
IT8547538A0 (it) 8 alfa-acilamminoergoline,loro preparazione e loro impiego come medicamenti
IL78693A0 (en) Pyridazinium compounds,their preparation and fungicidal and algicidal agents containing them
IL77106A0 (en) Homopropargylamines,their preparation and their use as fungicides
RO91273A (ro) Compozitie erbicida cu activitate prelungita
IT1200095B (it) Composti maftalenici, loro preparazione e loro impiego come medicamenti
GB8513962D0 (en) Compounds having antibacterial activity
GB2163051B (en) Drug composition for the treating or preventing acne by topical application
IT1176852B (it) Azetidinoni ad attivita' antibatterica
IL74181A0 (en) 1,3,2-dioxaborinanes,their preparation and their use as biocides
IL75366A0 (en) Substituted phenylsulphonylureas,their preparation and their use as plant-treatment agents
IT8420075A0 (it) Composti ad attivita'antibatterica.
BR8504405A (pt) Processo para preparacao de derivados de salicilamida,composicoes fungicidas,processo para combater fungos,aplicacao de tais derivados,e processo para preparacao de tais composicoes
IT1177830B (it) Desacetil ravidomicina dotata di attivita' antitumorale ed antibatterica e relativo procedimento di preparazione
IT8648049A0 (it) Composti azolici loro preparazione e loro impiego come antimicotici e fungicidi
IT8422221A0 (it) Composto ad attivita'spasmolitica, procedimento per lasua preparazione e composizioni farmaceutiche che lo contengono.
IT8123295A0 (it) Composti ad attivita' antibatterica e procedimento per la loro preparazione.
IT8123300A0 (it) Composti ad attivita' antibatterica e procedimento per la loro preparazione.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19930520